Home / Import refusals / 9UA-0287614-4/61/1D

FDA Import Refusal 9UA-0287614-4/61/1D — BALAXI HEALTHCARE DOMINICANA

BALAXI HEALTHCARE DOMINICANA — FEI 3015155413

The FDA refused shipment 9UA-0287614-4/61/1D from BALAXI HEALTHCARE DOMINICANA (Dominican Republic) on Mar 27, 2023. The refused product falls under Drugs and Biologics — AMPICILLIN TRIHYDRATE (PENICILLIN, SYNTHETICALLY PRODUCED). Cited charges: 118,75 This firm has 2 other import refusals on record.

Refusal details

Date
Mar 27, 2023
Country
Dominican Republic
Product Category
Drugs and Biologics
Product Code
56BCY07 AMPICILLIN TRIHYDRATE (PENICILLIN, SYNTHETICALLY PRODUCED)
Charges
118,75

Other import refusals

FDA data resources

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.